Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans
- PMID: 11136273
- DOI: 10.1046/j.1365-2036.2001.00898.x
Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans
Abstract
Background: Chronic nonsteroidal anti-inflammatory drug (NSAID) ingestion strongly affects the gastrointestinal mucosa as a first stage before ulceration. Some Lactobacillus strains may stabilize the mucosal barrier by increasing mucin expression, reducing bacterial overgrowth, stimulating mucosal immunity and synthetizing antioxidant substances; these events are altered in NSAID-associated gastroenteropathy.
Aim: To determine whether ingestion of the probiotic Lactobacillus GG (LGG) protects the gastrointestinal mucosa against indometacin-induced alterations of permeability.
Subjects and methods: Four gastrointestinal permeability tests were carried out in random order in 16 healthy volunteers: (i) basal; (ii) after indometacin; (iii) after 5 days of living LGG ingestion before indometacin administration; (iv) after 5 days of heat-killed LGG ingestion before indometacin administration.
Results: Indometacin significantly increased basal sucrose urinary excretion (29.6 mg [17.1-42.1] vs. 108.5 mg [68.2-148.7], P=0.0030) (means [95% CI]) and lactulose/mannitol urinary excretion (1.03% [0.73-1. 32] vs. 2.93% [1.96-3.90], P=0.00012). Heat-killed LGG did not modify the indometacin-induced increase of gastrointestinal permeability, while live bacteria significantly reduced the alteration of gastric (47.8 mg [31.1-64.6], P=0.012) but not intestinal permeability induced by NSAID.
Conclusions: Regular ingestion of LGG protects the integrity of the gastric mucosal barrier against indometacin, but has no effect at the intestinal level.
Similar articles
-
Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.J Pharm Pharmacol. 2003 May;55(5):661-8. doi: 10.1211/002235703765344577. J Pharm Pharmacol. 2003. PMID: 12831509
-
The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells.Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:133-8. doi: 10.1046/j.1365-2036.18.s1.15.x. Aliment Pharmacol Ther. 2003. PMID: 12925151
-
Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.Gut. 2001 Nov;49(5):650-5. doi: 10.1136/gut.49.5.650. Gut. 2001. PMID: 11600467 Free PMC article.
-
Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability.Aliment Pharmacol Ther. 1998 Apr;12(4):303-20. doi: 10.1046/j.1365-2036.1998.00300.x. Aliment Pharmacol Ther. 1998. PMID: 9690719 Review.
-
Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function.Scand J Gastroenterol Suppl. 1997;223:70-8. Scand J Gastroenterol Suppl. 1997. PMID: 9200310 Review.
Cited by
-
Unravelling the Gastroprotective Potential of Kefir: Exploring Antioxidant Effects in Preventing Gastric Ulcers.Cells. 2023 Dec 8;12(24):2799. doi: 10.3390/cells12242799. Cells. 2023. PMID: 38132119 Free PMC article.
-
How Microbes Affect Depression: Underlying Mechanisms via the Gut-Brain Axis and the Modulating Role of Probiotics.Int J Mol Sci. 2022 Jan 21;23(3):1172. doi: 10.3390/ijms23031172. Int J Mol Sci. 2022. PMID: 35163104 Free PMC article. Review.
-
Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity.Appl Environ Microbiol. 2005 Nov;71(11):7528-30. doi: 10.1128/AEM.71.11.7528-7530.2005. Appl Environ Microbiol. 2005. PMID: 16269795 Free PMC article.
-
Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent.Biomed Res Int. 2013;2013:620719. doi: 10.1155/2013/620719. Epub 2013 Aug 21. Biomed Res Int. 2013. PMID: 24027760 Free PMC article. Review.
-
Present and Future Therapeutic Approaches to Barrier Dysfunction.Front Nutr. 2021 Oct 28;8:718093. doi: 10.3389/fnut.2021.718093. eCollection 2021. Front Nutr. 2021. PMID: 34778332 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources